These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26605928)

  • 41. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis.
    Norman JE; Mackenzie F; Owen P; Mactier H; Hanretty K; Cooper S; Calder A; Mires G; Danielian P; Sturgiss S; MacLennan G; Tydeman G; Thornton S; Martin B; Thornton JG; Neilson JP; Norrie J
    Lancet; 2009 Jun; 373(9680):2034-40. PubMed ID: 19523680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effectiveness of progesterone in pregnancy complications].
    van der Hoorn MP; Lashley EELO
    Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31682091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage.
    Christiansen OB; Pedersen B; Rosgaard A; Husth M
    Hum Reprod; 2002 Mar; 17(3):809-16. PubMed ID: 11870141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent MiscarriageGreen-top Guideline No. 17.
    Regan L; Rai R; Saravelos S; Li TC;
    BJOG; 2023 Nov; 130(12):e9-e39. PubMed ID: 37334488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of early administration of rectal progesterone in IVF/ICSI twin pregnancies on the preterm birth rate: a randomized trial.
    Aboulghar MM; El-Faissal Y; Kamel A; Mansour R; Serour G; Aboulghar M; Islam Y
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):351. PubMed ID: 32517660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial.
    Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
    EClinicalMedicine; 2022 Aug; 50():101527. PubMed ID: 35795714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome.
    Alalaf S
    Arch Gynecol Obstet; 2012 Mar; 285(3):641-7. PubMed ID: 21842174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progestogen for preventing miscarriage.
    Oates-Whitehead RM; Haas DM; Carrier JA
    Cochrane Database Syst Rev; 2003; (4):CD003511. PubMed ID: 14583982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spontaneous first trimester miscarriage rates per woman among parous women with 1 or more pregnancies of 24 weeks or more.
    Cohain JS; Buxbaum RE; Mankuta D
    BMC Pregnancy Childbirth; 2017 Dec; 17(1):437. PubMed ID: 29272996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
    van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC
    Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW; Seto MTY; Ng EHY
    Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decrease in peripheral natural killer cell level during early pregnancy predicts live birth among women with unexplained recurrent pregnancy loss: a prospective cohort study.
    Ou M; Luo L; Yang Y; Yan N; Yan X; Zhong X; Cheong Y; Li T; Ouyang J; Wang Q
    Am J Obstet Gynecol; 2024 Jun; 230(6):675.e1-675.e13. PubMed ID: 37914060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
    de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
    Trials; 2015 May; 16():208. PubMed ID: 25947329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progestogen for preventing miscarriage.
    Haas DM; Ramsey PS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD003511. PubMed ID: 18425891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.